LifeStance Health Group, Inc.
LFST
$7.59
-$0.29-3.68%
| Weiss Ratings | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.02 | |||
| Price History | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.07% | |||
| 30-Day Total Return | -5.01% | |||
| 60-Day Total Return | 3.41% | |||
| 90-Day Total Return | 8.27% | |||
| Year to Date Total Return | 0.53% | |||
| 1-Year Total Return | 5.20% | |||
| 2-Year Total Return | 60.13% | |||
| 3-Year Total Return | -14.53% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -8.48% | |||
| 52-Week Low % Change | 69.83% | |||
| Price | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.61 | |||
| 52-Week Low Price | $4.64 | |||
| 52-Week Low Price (Date) | Jun 26, 2024 | |||
| 52-Week High Price (Date) | Nov 07, 2024 | |||
| Valuation | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.03B | |||
| Enterprise Value | 3.36B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.15 | |||
| Earnings Per Share Growth | -70.11% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.40 | |||
| Price/Book (Q) | 2.09 | |||
| Enterprise Value/Revenue (TTM) | 2.69 | |||
| Price | $7.59 | |||
| Enterprise Value/EBITDA (TTM) | 82.84 | |||
| Enterprise Value/EBIT | -110.64 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 380.45M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 602 767 2100 | |||
| Address | 4800 North Scottsdale Road Scottsdale, AZ 85251 | |||
| Website | lifestance.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2.42% | |||
| Profit Margin | -4.59% | |||
| Management Effectiveness | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.90% | |||
| Return on Equity | -- | |||
| Income Statement | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.25B | |||
| Total Revenue (TTM) | 1.25B | |||
| Revenue Per Share | $3.29 | |||
| Gross Profit (TTM) | 402.40M | |||
| EBITDA (TTM) | 40.57M | |||
| EBIT (TTM) | -30.38M | |||
| Net Income (TTM) | -57.44M | |||
| Net Income Avl. to Common (TTM) | -57.44M | |||
| Total Revenue Growth (Q YOY) | 15.99% | |||
| Earnings Growth (Q YOY) | 84.18% | |||
| EPS Diluted (TTM) | -0.15 | |||
| EPS Diluted Growth (Q YOY) | 84.72% | |||
| Balance Sheet | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 154.57M | |||
| Cash Per Share (Q) | $0.41 | |||
| Total Current Assets (Q) | 312.51M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.45B | |||
| Current Ratio (Q) | 1.365 | |||
| Book Value Per Share (Q) | $3.78 | |||
| Total Assets (Q) | 2.12B | |||
| Total Current Liabilities (Q) | 228.89M | |||
| Total Debt (Q) | 485.19M | |||
| Total Liabilities (Q) | 672.01M | |||
| Total Common Equity (Q) | 1.45B | |||
| Cash Flow | LFST - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -21.57M | |||
| Cash from Financing (TTM) | -9.95M | |||
| Net Change in Cash (TTM) | 75.75M | |||
| Levered Free Cash Flow (TTM) | 99.33M | |||
| Cash from Operations (TTM) | 107.26M | |||
